James M. Frincke, Ph.D. has been named president and chief executive officer of Hollis-Eden Pharmaceuticals, Inc. Dr. Frincke was also elected to the company’s board of directors. Dr. Frincke joined Hollis-Eden in 1997 as vice president, R&D, was promoted to executive vice president in 1999, and to chief scientific officer in 2001. He joined Hollis-Eden from Prolinx, Inc., where he served as vice president, Therapeutics R&D, from 1995 to 1997. During his 28 years in the biotechn...